Unichem gets USFDA approval for Apremilast Tablets

Unichem gets USFDA approval for Apremilast Tablets

Picture: Pixabay

Last Updated on February 22, 2021 by The Health Master

Unichem Laboratories has received ANDA approval for its Apremilast Tablets, 10 mg, 20 mg and 30 mg from the United States Food and Drug Administration (USFDA).

This approval is for marketing a generic version of Amgen’s Otezla (apremilast) Tablets, 10 mg, 20 mg, and 30 mg.

Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

Also read:

Lupin gets USFDA nod to market generic Droxidopa capsules

Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules

Zydus Cadila gets USFDA nod for low Blood Pressure drug

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.

Go to main website, click here

Follow and connect with us on Facebook and Linkedin

Subscribe for daily free updates, click here

For daily free updates on WhatsApp, click here

Subscribe here for daily updates